Gut microbiome study in colorectal cancer patients
Part of Cancer, Digestive system clinical trials.
This study looks at how bacteria and other microbes in your gut are linked to colorectal cancer risk and outcomes. By collecting stool samples from people newly diagnosed with colorectal cancer, researchers hope to find patterns that could improve understanding and future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Portugal.
- You are between 40 and 74 years old.
- You have just been diagnosed with colorectal cancer and have not started any treatment yet.
- You do not have a parent, sibling, or child who had colorectal cancer.
- You do not have ulcerative colitis, Crohn's disease, irritable bowel syndrome, or a history of recurrent C. diff infections.
- You are willing to provide stool samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in stool (poop) to detect colorectal cancer early. If you are between 40 and 74, live in the Lisbon area, and don't have certain digestive or cancer conditions, you may help improve screening by providing a stool sample.
This study looks at how chemicals in the environment (called endocrine disruptors) might affect the natural bacteria in your gut and whether that could play a role in colorectal cancer. If you are having a colonoscopy (endoscopy), you may be able to participate.
This trial studies how bile acids and gut bacteria are linked to early colorectal cancer. It may help identify patients at risk before cancer develops.
This study looks at how gut bacteria (the microbiome) change during treatment for colorectal cancer that has spread or cannot be removed. Researchers hope the findings may help improve understanding of how treatment works and how to tailor care.
This study looks at gut bacteria in people with colorectal cancer that has spread (metastatic). It aims to find patterns in the bacteria that may help doctors choose better treatments.
This trial tests a new tool that looks at gut bacteria to help find colorectal cancer earlier. It's for people who already had a positive result on a standard stool test (FIT) as part of a national screening program.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.